Great news for patients with headaches and chronic migraines.
In a follow-up study on the efficacy of neuromodulators to prevent headaches and chronic migraines BOTOX should be considered Level A in headache prevention and Level B improvement health-related qualify of life in chronic migraines.
- Published online before print April 18, 2016, doi: http://www.neurology.org/content/86/19/1818
The FDA has approved BOTOX for the following:
Indicated for prophylactic treatment of headaches in adults with chronic migraine, a distinct and severe neurological disorder characterized by patients with migraine history who suffer from headaches on 15 or more days/month. Headaches typically last four hours/day or longer.
The amount used for treatment is up to 155 u dose injection every 12 weeks depending on the patients clinical syndrome and metabolism of the drug. Other studies have shown lower dosages to be effective in just a singular area localized in the area only where the headaches occur. For example, injections the occipital muscles only for occipital migraines.